Manage Tickers Link Financial Account

Has my stock been accused of fraud?Join over 160k users who know.

Ticker	Price	Change($)	Change(%)	Shares	Volume	Prev Close	Open	Gain($)	Gain(%)

Ticker	Status	Jurisdiction	Filing Date	CP Start	CP End	CP Loss	Deadline

Ticker	Case Name	Status	CP Start	CP End	Deadline	Settlement Amt

Ticker	Name	Date	Analyst Firm	Up/Down	Target ($)	Rating Change	Rating Current

TD Cowen Upgrades Surgery Partners to Outperform, Lowers Price Target to $35

Author: Benzinga Newsdesk | November 14, 2023 08:30am

TD Cowen analyst Gary Taylor upgrades Surgery Partners (NASDAQ:SGRY) from Market Perform to Outperform and lowers the price target from $39 to $35.

Posted In: SGRY